A novel in vivo role for osteoprotegerin ligand in activation of monocyte effector function and inflammatory response.
about
Runx2-upregulated receptor activator of nuclear factor κB ligand in calcifying smooth muscle cells promotes migration and osteoclastic differentiation of macrophages.The roles of lipid oxidation products and receptor activator of nuclear factor-κB signaling in atherosclerotic calcificationSafety and tolerability of denosumab for the treatment of postmenopausal osteoporosis.Osteoclast precursors, RANKL/RANK, and immunology.Anti-RANKL treatment inhibits erosive joint destruction and lowers inflammation but has no effect on bone formation in the delayed-type hypersensitivity arthritis (DTHA) modelTGF-beta1 on osteoimmunology and the bone component cellsAssociation analyses suggest the effects of RANK and RANKL on age at menarche in Chinese women.Effects of RANKL-Targeted Therapy in Immunity and Cancer.RANKL enhances macrophage paracrine pro-calcific activity in high phosphate-treated smooth muscle cells: dependence on IL-6 and TNF-α.Do RANKL inhibitors (denosumab) affect inflammation and immunity?Pathophysiology of atypical femoral fractures and osteonecrosis of the jaw.Cell Signaling Pathways That Regulate Antigen PresentationMacrophages and skeletal health.Transcriptional regulation of human RANK ligand gene expression by E2F1.RANKL-mediated harmonious dialogue between fetus and mother guarantees smooth gestation by inducing decidual M2 macrophage polarization.ICOS-Ligand Triggering Impairs Osteoclast Differentiation and Function In Vitro and In Vivo.
P2860
Q34993353-6CA30151-758A-49C2-ABF7-252904E922B0Q35083231-F41B460A-A0ED-4658-B765-DB6777DA0807Q35689812-F1527A00-CA66-4FD2-AC84-0F24A3C0D619Q36324916-55409433-E6C5-49D3-BABB-2C4E759214E1Q36493751-A55F1A9B-8A0A-4647-AF74-6F6E4A4D392EQ36591727-608D918B-E491-493C-BEF6-9CD77A40DBC3Q36928773-DCCE0F5D-376B-407F-8213-88010CFC1CBCQ37441693-A70DFEBC-4E88-48AD-90BF-49A80E86AF59Q37727115-DC5102E2-D570-4AC4-B0D6-3310DABD3433Q37767159-0AC6D2E3-1C0F-473D-8264-0EFE84E68E33Q37945476-3CE104B1-AEA4-4E0E-BB60-0830C2FCA38AQ39002838-0E890E98-7519-4774-8236-FBA55FD4D201Q39129914-C6DA942C-3CE4-48C4-AAB4-F19F9DE97F5FQ39996337-8CA6B8FF-C1B7-448C-BF8B-165E14A53001Q47133428-ED77E83E-35D2-4451-8A66-C0293CCEEC50Q48261321-073B71A1-5FAC-46F5-9496-C98335253881
P2860
A novel in vivo role for osteoprotegerin ligand in activation of monocyte effector function and inflammatory response.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
A novel in vivo role for osteo ...... ion and inflammatory response.
@en
A novel in vivo role for osteo ...... ion and inflammatory response.
@nl
type
label
A novel in vivo role for osteo ...... ion and inflammatory response.
@en
A novel in vivo role for osteo ...... ion and inflammatory response.
@nl
prefLabel
A novel in vivo role for osteo ...... ion and inflammatory response.
@en
A novel in vivo role for osteo ...... ion and inflammatory response.
@nl
P2093
P2860
P356
P1476
A novel in vivo role for osteo ...... ion and inflammatory response.
@en
P2093
Dhaya Seshasayee
Iqbal S Grewal
Nicholas Van Bruggen
Peter Gribling
Richard Carano
Wyne P Lee
P2860
P304
30202-30209
P356
10.1074/JBC.M403968200
P407
P577
2004-05-15T00:00:00Z